Summary

Summary

According to APO Research, the global Amlodipine Besylate market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Amlodipine Besylate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Amlodipine Besylate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Amlodipine Besylate is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Amlodipine Besylate include Alkem Laboratories, Apotex, Aurobindo Pharma, Cipla, CR Pharmaceutical, Dr. Reddy's Laboratories, Epic Pharma, Hikma Pharmaceuticals and InvaGen Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Amlodipine Besylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amlodipine Besylate.

The report will help the Amlodipine Besylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Amlodipine Besylate Segment by Company

Alkem Laboratories
Apotex
Aurobindo Pharma
Cipla
CR Pharmaceutical
Dr. Reddy's Laboratories
Epic Pharma
Hikma Pharmaceuticals
InvaGen Pharmaceuticals
Lupin Pharmaceuticals
MACLEODS
Oxford Pharm
Strides Pharma
Teva Pharmaceutical
Upsher-Smith Laboratories
Wockhardt
Zydus Pharmaceuticals
Pfizer
Mylan
Sun Pharmaceutical

Amlodipine Besylate Segment by Type
10mg Tablets
2.5mg Tablets
5mg Tablets

Amlodipine Besylate Segment by Application
High Blood Pressure
Heart Disease

Amlodipine Besylate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amlodipine Besylate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amlodipine Besylate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amlodipine Besylate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amlodipine Besylate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amlodipine Besylate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amlodipine Besylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

ページTOPに戻る

Table of Contents

1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources

2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Amlodipine Besylate Market Size (2020-2031)
2.2.2 Global Amlodipine Besylate Sales (2020-2031)
2.2.3 Global Amlodipine Besylate Market Average Price (2020-2031)
2.3 Amlodipine Besylate by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 10mg Tablets
2.3.3 2.5mg Tablets
2.3.4 5mg Tablets
2.4 Amlodipine Besylate by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 High Blood Pressure
2.4.3 Heart Disease

3 Market Competitive Landscape by Manufacturers
3.1 Global Amlodipine Besylate Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Amlodipine Besylate Sales (W Units) of Manufacturers (2020-2025)
3.3 Global Amlodipine Besylate Revenue of Manufacturers (2020-2025)
3.4 Global Amlodipine Besylate Average Price by Manufacturers (2020-2025)
3.5 Global Amlodipine Besylate Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Amlodipine Besylate, Product Type & Application
3.8 Global Manufacturers of Amlodipine Besylate, Established Date
3.9 Global Amlodipine Besylate Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition

4 Manufacturers Profiled
4.1 Alkem Laboratories
4.1.1 Alkem Laboratories Company Information
4.1.2 Alkem Laboratories Business Overview
4.1.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Alkem Laboratories Amlodipine Besylate Product Portfolio
4.1.5 Alkem Laboratories Recent Developments
4.2 Apotex
4.2.1 Apotex Company Information
4.2.2 Apotex Business Overview
4.2.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Apotex Amlodipine Besylate Product Portfolio
4.2.5 Apotex Recent Developments
4.3 Aurobindo Pharma
4.3.1 Aurobindo Pharma Company Information
4.3.2 Aurobindo Pharma Business Overview
4.3.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Aurobindo Pharma Amlodipine Besylate Product Portfolio
4.3.5 Aurobindo Pharma Recent Developments
4.4 Cipla
4.4.1 Cipla Company Information
4.4.2 Cipla Business Overview
4.4.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Cipla Amlodipine Besylate Product Portfolio
4.4.5 Cipla Recent Developments
4.5 CR Pharmaceutical
4.5.1 CR Pharmaceutical Company Information
4.5.2 CR Pharmaceutical Business Overview
4.5.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.5.4 CR Pharmaceutical Amlodipine Besylate Product Portfolio
4.5.5 CR Pharmaceutical Recent Developments
4.6 Dr. Reddy's Laboratories
4.6.1 Dr. Reddy's Laboratories Company Information
4.6.2 Dr. Reddy's Laboratories Business Overview
4.6.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Dr. Reddy's Laboratories Amlodipine Besylate Product Portfolio
4.6.5 Dr. Reddy's Laboratories Recent Developments
4.7 Epic Pharma
4.7.1 Epic Pharma Company Information
4.7.2 Epic Pharma Business Overview
4.7.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Epic Pharma Amlodipine Besylate Product Portfolio
4.7.5 Epic Pharma Recent Developments
4.8 Hikma Pharmaceuticals
4.8.1 Hikma Pharmaceuticals Company Information
4.8.2 Hikma Pharmaceuticals Business Overview
4.8.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Hikma Pharmaceuticals Amlodipine Besylate Product Portfolio
4.8.5 Hikma Pharmaceuticals Recent Developments
4.9 InvaGen Pharmaceuticals
4.9.1 InvaGen Pharmaceuticals Company Information
4.9.2 InvaGen Pharmaceuticals Business Overview
4.9.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.9.4 InvaGen Pharmaceuticals Amlodipine Besylate Product Portfolio
4.9.5 InvaGen Pharmaceuticals Recent Developments
4.10 Lupin Pharmaceuticals
4.10.1 Lupin Pharmaceuticals Company Information
4.10.2 Lupin Pharmaceuticals Business Overview
4.10.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Lupin Pharmaceuticals Amlodipine Besylate Product Portfolio
4.10.5 Lupin Pharmaceuticals Recent Developments
4.11 MACLEODS
4.11.1 MACLEODS Company Information
4.11.2 MACLEODS Business Overview
4.11.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.11.4 MACLEODS Amlodipine Besylate Product Portfolio
4.11.5 MACLEODS Recent Developments
4.12 Oxford Pharm
4.12.1 Oxford Pharm Company Information
4.12.2 Oxford Pharm Business Overview
4.12.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Oxford Pharm Amlodipine Besylate Product Portfolio
4.12.5 Oxford Pharm Recent Developments
4.13 Strides Pharma
4.13.1 Strides Pharma Company Information
4.13.2 Strides Pharma Business Overview
4.13.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Strides Pharma Amlodipine Besylate Product Portfolio
4.13.5 Strides Pharma Recent Developments
4.14 Teva Pharmaceutical
4.14.1 Teva Pharmaceutical Company Information
4.14.2 Teva Pharmaceutical Business Overview
4.14.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Teva Pharmaceutical Amlodipine Besylate Product Portfolio
4.14.5 Teva Pharmaceutical Recent Developments
4.15 Upsher-Smith Laboratories
4.15.1 Upsher-Smith Laboratories Company Information
4.15.2 Upsher-Smith Laboratories Business Overview
4.15.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Upsher-Smith Laboratories Amlodipine Besylate Product Portfolio
4.15.5 Upsher-Smith Laboratories Recent Developments
4.16 Wockhardt
4.16.1 Wockhardt Company Information
4.16.2 Wockhardt Business Overview
4.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Wockhardt Amlodipine Besylate Product Portfolio
4.16.5 Wockhardt Recent Developments
4.17 Zydus Pharmaceuticals
4.17.1 Zydus Pharmaceuticals Company Information
4.17.2 Zydus Pharmaceuticals Business Overview
4.17.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Zydus Pharmaceuticals Amlodipine Besylate Product Portfolio
4.17.5 Zydus Pharmaceuticals Recent Developments
4.18 Pfizer
4.18.1 Pfizer Company Information
4.18.2 Pfizer Business Overview
4.18.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.18.4 Pfizer Amlodipine Besylate Product Portfolio
4.18.5 Pfizer Recent Developments
4.19 Mylan
4.19.1 Mylan Company Information
4.19.2 Mylan Business Overview
4.19.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.19.4 Mylan Amlodipine Besylate Product Portfolio
4.19.5 Mylan Recent Developments
4.20 Sun Pharmaceutical
4.20.1 Sun Pharmaceutical Company Information
4.20.2 Sun Pharmaceutical Business Overview
4.20.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2020-2025)
4.20.4 Sun Pharmaceutical Amlodipine Besylate Product Portfolio
4.20.5 Sun Pharmaceutical Recent Developments

5 Global Amlodipine Besylate Market Scenario by Region
5.1 Global Amlodipine Besylate Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Amlodipine Besylate Sales by Region: 2020-2031
5.2.1 Global Amlodipine Besylate Sales by Region: 2020-2025
5.2.2 Global Amlodipine Besylate Sales by Region: 2026-2031
5.3 Global Amlodipine Besylate Revenue by Region: 2020-2031
5.3.1 Global Amlodipine Besylate Revenue by Region: 2020-2025
5.3.2 Global Amlodipine Besylate Revenue by Region: 2026-2031
5.4 North America Amlodipine Besylate Market Facts & Figures by Country
5.4.1 North America Amlodipine Besylate Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Amlodipine Besylate Sales by Country (2020-2031)
5.4.3 North America Amlodipine Besylate Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Amlodipine Besylate Market Facts & Figures by Country
5.5.1 Europe Amlodipine Besylate Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Amlodipine Besylate Sales by Country (2020-2031)
5.5.3 Europe Amlodipine Besylate Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Amlodipine Besylate Market Facts & Figures by Country
5.6.1 Asia Pacific Amlodipine Besylate Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Amlodipine Besylate Sales by Country (2020-2031)
5.6.3 Asia Pacific Amlodipine Besylate Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Amlodipine Besylate Market Facts & Figures by Country
5.7.1 South America Amlodipine Besylate Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Amlodipine Besylate Sales by Country (2020-2031)
5.7.3 South America Amlodipine Besylate Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Amlodipine Besylate Market Facts & Figures by Country
5.8.1 Middle East and Africa Amlodipine Besylate Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Amlodipine Besylate Sales by Country (2020-2031)
5.8.3 Middle East and Africa Amlodipine Besylate Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE

6 Segment by Type
6.1 Global Amlodipine Besylate Sales by Type (2020-2031)
6.1.1 Global Amlodipine Besylate Sales by Type (2020-2031) & (W Units)
6.1.2 Global Amlodipine Besylate Sales Market Share by Type (2020-2031)
6.2 Global Amlodipine Besylate Revenue by Type (2020-2031)
6.2.1 Global Amlodipine Besylate Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Amlodipine Besylate Revenue Market Share by Type (2020-2031)
6.3 Global Amlodipine Besylate Price by Type (2020-2031)

7 Segment by Application
7.1 Global Amlodipine Besylate Sales by Application (2020-2031)
7.1.1 Global Amlodipine Besylate Sales by Application (2020-2031) & (W Units)
7.1.2 Global Amlodipine Besylate Sales Market Share by Application (2020-2031)
7.2 Global Amlodipine Besylate Revenue by Application (2020-2031)
7.2.1 Global Amlodipine Besylate Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Amlodipine Besylate Revenue Market Share by Application (2020-2031)
7.3 Global Amlodipine Besylate Price by Application (2020-2031)

8 Value Chain and Sales Channels Analysis of the Market
8.1 Amlodipine Besylate Value Chain Analysis
8.1.1 Amlodipine Besylate Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Amlodipine Besylate Production Mode & Process
8.2 Amlodipine Besylate Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Amlodipine Besylate Distributors
8.2.3 Amlodipine Besylate Customers

9 Global Amlodipine Besylate Analyzing Market Dynamics
9.1 Amlodipine Besylate Industry Trends
9.2 Amlodipine Besylate Industry Drivers
9.3 Amlodipine Besylate Industry Opportunities and Challenges
9.4 Amlodipine Besylate Industry Restraints

10 Report Conclusion
11 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5. Global Amlodipine Besylate Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
Table 6. Global Amlodipine Besylate Sales (W Units) of Manufacturers (2020-2025)
Table 7. Global Amlodipine Besylate Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Amlodipine Besylate Revenue of Manufacturers (2020-2025)
Table 9. Global Amlodipine Besylate Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Amlodipine Besylate Average Price (US$/Unit) of Manufacturers (2020-2025)
Table 11. Global Amlodipine Besylate Industry Ranking, 2023 VS 2024 VS 2025
Table 12. Global Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Amlodipine Besylate, Product Type & Application
Table 14. Global Amlodipine Besylate Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Amlodipine Besylate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Alkem Laboratories Company Information
Table 19. Alkem Laboratories Business Overview
Table 20. Alkem Laboratories Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 21. Alkem Laboratories Amlodipine Besylate Product Portfolio
Table 22. Alkem Laboratories Recent Developments
Table 23. Apotex Company Information
Table 24. Apotex Business Overview
Table 25. Apotex Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 26. Apotex Amlodipine Besylate Product Portfolio
Table 27. Apotex Recent Developments
Table 28. Aurobindo Pharma Company Information
Table 29. Aurobindo Pharma Business Overview
Table 30. Aurobindo Pharma Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 31. Aurobindo Pharma Amlodipine Besylate Product Portfolio
Table 32. Aurobindo Pharma Recent Developments
Table 33. Cipla Company Information
Table 34. Cipla Business Overview
Table 35. Cipla Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 36. Cipla Amlodipine Besylate Product Portfolio
Table 37. Cipla Recent Developments
Table 38. CR Pharmaceutical Company Information
Table 39. CR Pharmaceutical Business Overview
Table 40. CR Pharmaceutical Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 41. CR Pharmaceutical Amlodipine Besylate Product Portfolio
Table 42. CR Pharmaceutical Recent Developments
Table 43. Dr. Reddy's Laboratories Company Information
Table 44. Dr. Reddy's Laboratories Business Overview
Table 45. Dr. Reddy's Laboratories Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 46. Dr. Reddy's Laboratories Amlodipine Besylate Product Portfolio
Table 47. Dr. Reddy's Laboratories Recent Developments
Table 48. Epic Pharma Company Information
Table 49. Epic Pharma Business Overview
Table 50. Epic Pharma Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 51. Epic Pharma Amlodipine Besylate Product Portfolio
Table 52. Epic Pharma Recent Developments
Table 53. Hikma Pharmaceuticals Company Information
Table 54. Hikma Pharmaceuticals Business Overview
Table 55. Hikma Pharmaceuticals Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. Hikma Pharmaceuticals Amlodipine Besylate Product Portfolio
Table 57. Hikma Pharmaceuticals Recent Developments
Table 58. InvaGen Pharmaceuticals Company Information
Table 59. InvaGen Pharmaceuticals Business Overview
Table 60. InvaGen Pharmaceuticals Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 61. InvaGen Pharmaceuticals Amlodipine Besylate Product Portfolio
Table 62. InvaGen Pharmaceuticals Recent Developments
Table 63. Lupin Pharmaceuticals Company Information
Table 64. Lupin Pharmaceuticals Business Overview
Table 65. Lupin Pharmaceuticals Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 66. Lupin Pharmaceuticals Amlodipine Besylate Product Portfolio
Table 67. Lupin Pharmaceuticals Recent Developments
Table 68. MACLEODS Company Information
Table 69. MACLEODS Business Overview
Table 70. MACLEODS Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 71. MACLEODS Amlodipine Besylate Product Portfolio
Table 72. MACLEODS Recent Developments
Table 73. Oxford Pharm Company Information
Table 74. Oxford Pharm Business Overview
Table 75. Oxford Pharm Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Oxford Pharm Amlodipine Besylate Product Portfolio
Table 77. Oxford Pharm Recent Developments
Table 78. Strides Pharma Company Information
Table 79. Strides Pharma Business Overview
Table 80. Strides Pharma Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Strides Pharma Amlodipine Besylate Product Portfolio
Table 82. Strides Pharma Recent Developments
Table 83. Teva Pharmaceutical Company Information
Table 84. Teva Pharmaceutical Business Overview
Table 85. Teva Pharmaceutical Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Teva Pharmaceutical Amlodipine Besylate Product Portfolio
Table 87. Teva Pharmaceutical Recent Developments
Table 88. Upsher-Smith Laboratories Company Information
Table 89. Upsher-Smith Laboratories Business Overview
Table 90. Upsher-Smith Laboratories Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Upsher-Smith Laboratories Amlodipine Besylate Product Portfolio
Table 92. Upsher-Smith Laboratories Recent Developments
Table 93. Wockhardt Company Information
Table 94. Wockhardt Business Overview
Table 95. Wockhardt Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Wockhardt Amlodipine Besylate Product Portfolio
Table 97. Wockhardt Recent Developments
Table 98. Zydus Pharmaceuticals Company Information
Table 99. Zydus Pharmaceuticals Business Overview
Table 100. Zydus Pharmaceuticals Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Zydus Pharmaceuticals Amlodipine Besylate Product Portfolio
Table 102. Zydus Pharmaceuticals Recent Developments
Table 103. Pfizer Company Information
Table 104. Pfizer Business Overview
Table 105. Pfizer Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Pfizer Amlodipine Besylate Product Portfolio
Table 107. Pfizer Recent Developments
Table 108. Mylan Company Information
Table 109. Mylan Business Overview
Table 110. Mylan Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Mylan Amlodipine Besylate Product Portfolio
Table 112. Mylan Recent Developments
Table 113. Sun Pharmaceutical Company Information
Table 114. Sun Pharmaceutical Business Overview
Table 115. Sun Pharmaceutical Amlodipine Besylate Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Sun Pharmaceutical Amlodipine Besylate Product Portfolio
Table 117. Sun Pharmaceutical Recent Developments
Table 118. Global Amlodipine Besylate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 119. Global Amlodipine Besylate Sales by Region (2020-2025) & (W Units)
Table 120. Global Amlodipine Besylate Sales Market Share by Region (2020-2025)
Table 121. Global Amlodipine Besylate Sales by Region (2026-2031) & (W Units)
Table 122. Global Amlodipine Besylate Sales Market Share by Region (2026-2031)
Table 123. Global Amlodipine Besylate Revenue by Region (2020-2025) & (US$ Million)
Table 124. Global Amlodipine Besylate Revenue Market Share by Region (2020-2025)
Table 125. Global Amlodipine Besylate Revenue by Region (2026-2031) & (US$ Million)
Table 126. Global Amlodipine Besylate Revenue Market Share by Region (2026-2031)
Table 127. North America Amlodipine Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 128. North America Amlodipine Besylate Sales by Country (2020-2025) & (W Units)
Table 129. North America Amlodipine Besylate Sales by Country (2026-2031) & (W Units)
Table 130. North America Amlodipine Besylate Revenue by Country (2020-2025) & (US$ Million)
Table 131. North America Amlodipine Besylate Revenue by Country (2026-2031) & (US$ Million)
Table 132. Europe Amlodipine Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 133. Europe Amlodipine Besylate Sales by Country (2020-2025) & (W Units)
Table 134. Europe Amlodipine Besylate Sales by Country (2026-2031) & (W Units)
Table 135. Europe Amlodipine Besylate Revenue by Country (2020-2025) & (US$ Million)
Table 136. Europe Amlodipine Besylate Revenue by Country (2026-2031) & (US$ Million)
Table 137. Asia Pacific Amlodipine Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 138. Asia Pacific Amlodipine Besylate Sales by Country (2020-2025) & (W Units)
Table 139. Asia Pacific Amlodipine Besylate Sales by Country (2026-2031) & (W Units)
Table 140. Asia Pacific Amlodipine Besylate Revenue by Country (2020-2025) & (US$ Million)
Table 141. Asia Pacific Amlodipine Besylate Revenue by Country (2026-2031) & (US$ Million)
Table 142. South America Amlodipine Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 143. South America Amlodipine Besylate Sales by Country (2020-2025) & (W Units)
Table 144. South America Amlodipine Besylate Sales by Country (2026-2031) & (W Units)
Table 145. South America Amlodipine Besylate Revenue by Country (2020-2025) & (US$ Million)
Table 146. South America Amlodipine Besylate Revenue by Country (2026-2031) & (US$ Million)
Table 147. Middle East and Africa Amlodipine Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 148. Middle East and Africa Amlodipine Besylate Sales by Country (2020-2025) & (W Units)
Table 149. Middle East and Africa Amlodipine Besylate Sales by Country (2026-2031) & (W Units)
Table 150. Middle East and Africa Amlodipine Besylate Revenue by Country (2020-2025) & (US$ Million)
Table 151. Middle East and Africa Amlodipine Besylate Revenue by Country (2026-2031) & (US$ Million)
Table 152. Global Amlodipine Besylate Sales by Type (2020-2025) & (W Units)
Table 153. Global Amlodipine Besylate Sales by Type (2026-2031) & (W Units)
Table 154. Global Amlodipine Besylate Sales Market Share by Type (2020-2025)
Table 155. Global Amlodipine Besylate Sales Market Share by Type (2026-2031)
Table 156. Global Amlodipine Besylate Revenue by Type (2020-2025) & (US$ Million)
Table 157. Global Amlodipine Besylate Revenue by Type (2026-2031) & (US$ Million)
Table 158. Global Amlodipine Besylate Revenue Market Share by Type (2020-2025)
Table 159. Global Amlodipine Besylate Revenue Market Share by Type (2026-2031)
Table 160. Global Amlodipine Besylate Price by Type (2020-2025) & (US$/Unit)
Table 161. Global Amlodipine Besylate Price by Type (2026-2031) & (US$/Unit)
Table 162. Global Amlodipine Besylate Sales by Application (2020-2025) & (W Units)
Table 163. Global Amlodipine Besylate Sales by Application (2026-2031) & (W Units)
Table 164. Global Amlodipine Besylate Sales Market Share by Application (2020-2025)
Table 165. Global Amlodipine Besylate Sales Market Share by Application (2026-2031)
Table 166. Global Amlodipine Besylate Revenue by Application (2020-2025) & (US$ Million)
Table 167. Global Amlodipine Besylate Revenue by Application (2026-2031) & (US$ Million)
Table 168. Global Amlodipine Besylate Revenue Market Share by Application (2020-2025)
Table 169. Global Amlodipine Besylate Revenue Market Share by Application (2026-2031)
Table 170. Global Amlodipine Besylate Price by Application (2020-2025) & (US$/Unit)
Table 171. Global Amlodipine Besylate Price by Application (2026-2031) & (US$/Unit)
Table 172. Key Raw Materials
Table 173. Raw Materials Key Suppliers
Table 174. Amlodipine Besylate Distributors List
Table 175. Amlodipine Besylate Customers List
Table 176. Amlodipine Besylate Industry Trends
Table 177. Amlodipine Besylate Industry Drivers
Table 178. Amlodipine Besylate Industry Restraints
Table 179. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Amlodipine Besylate Product Image
Figure 5. Global Amlodipine Besylate Revenue (US$ Million), 2020 VS 2024 VS 2031
Figure 6. Global Amlodipine Besylate Market Size (2020-2031) & (US$ Million)
Figure 7. Global Amlodipine Besylate Sales (2020-2031) & (W Units)
Figure 8. Global Amlodipine Besylate Average Price (US$/Unit) & (2020-2031)
Figure 9. 10mg Tablets Product Image
Figure 10. 2.5mg Tablets Product Image
Figure 11. 5mg Tablets Product Image
Figure 12. High Blood Pressure Product Image
Figure 13. Heart Disease Product Image
Figure 14. Global Amlodipine Besylate Revenue Share by Manufacturers in 2024
Figure 15. Global Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Amlodipine Besylate Players Market Share by Revenue in 2024
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 18. Global Amlodipine Besylate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 19. Global Amlodipine Besylate Sales by Region in 2024
Figure 20. Global Amlodipine Besylate Revenue by Region in 2024
Figure 21. North America Amlodipine Besylate Market Size by Country in 2024
Figure 22. North America Amlodipine Besylate Sales Market Share by Country (2020-2031)
Figure 23. North America Amlodipine Besylate Revenue Market Share by Country (2020-2031)
Figure 24. United States Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Amlodipine Besylate Market Size by Country in 2024
Figure 27. Europe Amlodipine Besylate Sales Market Share by Country (2020-2031)
Figure 28. Europe Amlodipine Besylate Revenue Market Share by Country (2020-2031)
Figure 29. Germany Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Netherlands Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Amlodipine Besylate Market Size by Country in 2024
Figure 35. Asia Pacific Amlodipine Besylate Sales Market Share by Country (2020-2031)
Figure 36. Asia Pacific Amlodipine Besylate Revenue Market Share by Country (2020-2031)
Figure 37. China Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. South America Amlodipine Besylate Market Size by Country in 2024
Figure 46. South America Amlodipine Besylate Sales Market Share by Country (2020-2031)
Figure 47. South America Amlodipine Besylate Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Amlodipine Besylate Market Size by Country in 2024
Figure 52. Middle East and Africa Amlodipine Besylate Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Amlodipine Besylate Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Amlodipine Besylate Sales Market Share by Type (2020-2031)
Figure 58. Global Amlodipine Besylate Revenue Market Share by Type (2020-2031)
Figure 59. Global Amlodipine Besylate Price (US$/Unit) by Type (2020-2031)
Figure 60. Global Amlodipine Besylate Sales Market Share by Application (2020-2031)
Figure 61. Global Amlodipine Besylate Revenue Market Share by Application (2020-2031)
Figure 62. Global Amlodipine Besylate Price (US$/Unit) by Application (2020-2031)
Figure 63. Amlodipine Besylate Value Chain
Figure 64. Amlodipine Besylate Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Amlodipine Besylate Industry Opportunities and Challenges